Has Angela Clemente received payments from drug or device companies?

Yes. Drug and device makers reported $2,791 in general payments to Angela Clemente across 112 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Angela Clemente did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Angela Clemente come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Angela Clemente

Pediatrics · House Springs, MONPI 1144290602

Payments from drug & device makers

$2,791in general payments, 2019–2025

Across 112 payments — averaging $24.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Avanir Pharmaceuticals, Inc.$717
Sunovion Pharmaceuticals Inc.$560
Otsuka America Pharmaceutical, Inc.$296
Vanda Pharmaceuticals Inc.$236
Johnson & Johnson$230
Otsuka Pharmaceutical Development & Commercialization, Inc.$214
plus $537 from 12 others

$1,078in research payments, 2019–2025

Across 6 payments — averaging $179.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Otsuka Pharmaceutical Development & Commercialization, Inc.$1K

What the payments were for

Travel & lodging$56320%
Food & beverage$2,18878%
Education$401%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Avanir Pharmaceuticals, Inc.	8	$717
Sunovion Pharmaceuticals Inc.	31	$560
Otsuka America Pharmaceutical, Inc.	21	$296
Vanda Pharmaceuticals Inc.	11	$236
Johnson & Johnson	14	$230
Otsuka Pharmaceutical Development & Commercialization, Inc.	2	$214
Alkermes, Inc.	10	$170
Janssen Scientific Affairs, LLC	1	$128
Indivior Inc.	2	$42
Genentech, Inc.	1	$40
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$34
Neurocrine Biosciences, Inc.	2	$26
Adlon Therapeutics L.p.	2	$24
Jazz Pharmaceuticals Inc.	1	$17
Eisai Inc.	1	$17
Orexo US, Inc.	1	$16
Arbor Pharmaceuticals, Inc.	1	$13
Takeda Pharmaceuticals U.S.A., Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SPRAVATO$128

How this compares

$2,791 in reported general payments places this provider in the 90th percentile of 1,306 pediatrics providers in Missouri.

See all pediatrics providers in Missouri →

Other pediatrics in House Springs

Kathleen DoisyColumbia$70.4M
Nadine MokhallatiKansas City$10.2M
Jennifer DiltsKansas City$517K
Abbey MasonbrinkKansas City$505K
Craig SpiegelBridgeton$494K
Amanda NedvedKansas City$201K
Jennifer HeithausSaint Louis$182K
Alexander FaySaint Louis$118K
Jennifer GoldmanKansas City$114K
David GoldsteinColumbia$83K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →